Le Pecq, November 9th, 2021
Evolucare is proud to announce the success of its €18 million financing with institutional investors through a private placement in a Euro PP bond format.
These funds will enable the group to accelerate its growth in its core business, in innovation and in its international ambitions. This growth will be achieved organically by financing the group’s transformation in its most strategic markets, and will also be achieved through external growth. Acquisitions along these lines will be announced shortly.
The bond issue, with a 7-year maturity and redeemable at maturity, is also structured with ESG performance indicators (Sustainability-linked Bond format) reflecting the Evolucare group’s strong and ambitious commitment to Corporate Social Responsibility.
Our partner Essling Capital and the Evolucare team would like to thank Crédit Agricole Brie Picardie, Evolucare’s first banking partner, Crédit Agricole CIB for its role as arranger and ESG structurer, and our new financial partners Aviva Investors France and Tikehau Capital.
“Thanks to this investment, Evolucare will reach the critical size that will allow it to position itself as a key player in the healthcare software industry on a European scale,” said Elie Le Guilcher, Founder and Chairman of Evolucare Group.
“This round of financing marks a new stage in the group’s growth. It allows us to strengthen the competitiveness of our solutions in our historical markets and to strategically position the group to prepare the healthcare solutions of tomorrow” adds Philippe Blanco, CEO of the Evolucare group.
“This successful transaction confirms Evolucare’s credit quality well received by top tier investors for a successful French growing company operating in the dynamic healthcare software market” concludes Thong Nguon, Executive Director Debt Capital Markets at Crédit Agricole CIB.
We would also like to thank Gide Loyrette Nouel A.A.R.P.I, legal advisor to the transaction, and Lys Avocats.
Download the press release (french)
